Super cool advancement using the largest single adjuvant melanoma cohort. Here you see how gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade: Cell www.cell.com/cell/fulltex...
cell.com
Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade
In 674 high-risk melanoma patients across five regions, the gut microbiome differs
by region but remains stable during ICB treatment, and region-specific bacterial markers
predict relapse.
